Reaction
Vulvovaginal Inflammation reporting signals
As of the last recalculation, Vulvovaginal Inflammation appears in 434 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 255.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Miconazole Nitrate | 42 | 255.4 | 256.6 |
| Bleomycin Sulfate | 11 | 52.4 | 52.4 |
| Pitavastatin Calcium | 8 | 38.2 | 38.2 |
| Baricitinib | 7 | 35.4 | 35.4 |
| Etonogestrel | 6 | 6.1 | 6.1 |